✅ #GUIDE-HF trial: haemodynamic guided management may reduce #heartfailure hospitalisations in patients with earlier stage #HF

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #EMPEROR-Pooled trial: a pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #SMART-MI trial: Remote monitoring of implantable #cardiac monitors is highly effective for early detection of serious #arrhythmias in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced EF

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #MASTERDAPT trial: 1 month of #DAPT following #stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #ENVISAGE-TAVI AF trial: edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients with #AFIb after #TAVI

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #FIGARO-DKD trial: finerenone reduces the risk of #cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 #diabetes

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #FIDELITY Analysis: finerenone reduces the risk of #CV and renal outcomes compared to placebo in patients with type 2 #diabetes and all stages of kidney disease

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #APAF-CRT trial: ablation plus #CRT is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent #AFib patients with a narrow QRS

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅#DECAAF II trial: fibrosis #ablation shows promise in #AFib with low grade fibrotic myopathy

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #TOMAHAWK trial: early coronary #angiography in out-of-hospital #CardiacArrest patients without ST-segment elevation is not superior to a delayed/selective approach

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫